Page results
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
UCLH will play a vital role in a new respiratory virus study.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata!
-
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.
-
As a mark of respect for the funeral of Her Majesty The Queen on Monday 19 September, we are postponing our Annual Members’ Meeting, which was scheduled for this date.
-
A tribute to Her Majesty The Queen
File results
-
FOI/2023/0299 - Trust Medical Examiner contact details
-
FOI/2023/0338 - Individuals with a change to a gene called CACNA1C for 2021 and 2022
-
FOI/2023/0351 - Senior staff contact details for non-clinical workforce
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0341 - Senior staff contact details
-
FOI/2023/0340 - NHS charging of overseas visitors
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2020/0002 - Surgical tools left inside patients